The Team

Sharon Choe, Managing Director

Sharon Choe has nearly 30 years of experience in the life sciences industry as an investor relations professional, buy-side analyst and investor covering life sciences, pharmaceuticals and medical technology companies. Prior to joining Rx Communications, Sharon was Head of Investor Relations at Ocugen, a publicly-traded life sciences company focused on rare retinal diseases. Earlier, she served as Senior Vice President at LaVoieHealthScience where she headed outreach, corporate access, investor relations and business development for small- to mid-cap life sciences companies. Before that, she served as Senior Vice President at The Ruth Group and Managing Director at LifeSci Advisors, both healthcare-focused investor relations agencies for public and private companies.

Early in her career, Sharon co-managed the global healthcare portfolio at Credit Suisse Asset Management in New York, and prior to that, was the Healthcare Analyst at UBS Asset Management covering mid to large-cap biotechnology, pharmaceuticals and medical technology companies.

Sharon graduated from Northeastern University with a Bachelor of Science in Pharmacy.